FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106867787> ?p ?o ?g. }

• W2106867787 endingPage "562" @default.
• W2106867787 startingPage "555" @default.
• W2106867787 abstract "Defects in Fas-mediated apoptosis are implicated in autoimmune diseases including rheumatoid arthritis (RA). Although induction of Fas-mediated apoptosis could have therapeutic effects on these diseases, it might cause deleterious effects in liver as Fas ligand or an agonistic anti-murine Fas antibody Jo2 causes severe hepatic injury in mice. We report here on the interesting characteristics of the newly obtained anti-Fas mAb, HFE7A, which cross-reacts with the Fas molecules of various species ranging from human to mouse and mitigates autoimmune symptoms without hepatotoxicity in mice. The administration of HFE7A to mice induced apoptosis in the thymocytes, although administration of HFE7A to mice or to marmosets did not induce any sign of hepatitis. The effect of HFE7A on liver is different from that of anti-murine Fas antibody Jo2, which causes acute and lethal hepatic injury to mice. Administration of HFE7A reduced lymphadenopathy and abnormal T cells in MRL-gld/gld mice. HFE7A induced apoptosis in synovial cells prepared from RA patients. Surprisingly, HFE7A protected mice from fulminant hepatitis induced by Jo2. Therefore, HFE7A is a potential therapeutic antibody not only for autoimmune diseases including RA but also for fulminant hepatitis." @default.
• W2106867787 created "2016-06-24" @default.
• W2106867787 creator A5005814559 @default.
• W2106867787 creator A5009949893 @default.
• W2106867787 creator A5024900910 @default.
• W2106867787 creator A5028034613 @default.
• W2106867787 creator A5036360676 @default.
• W2106867787 creator A5045619704 @default.
• W2106867787 creator A5050918148 @default.
• W2106867787 creator A5063118578 @default.
• W2106867787 creator A5065959133 @default.
• W2106867787 creator A5069360454 @default.
• W2106867787 creator A5075593407 @default.
• W2106867787 creator A5090769439 @default.
• W2106867787 date "2000-04-01" @default.
• W2106867787 modified "2023-10-16" @default.
• W2106867787 title "A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity" @default.
• W2106867787 cites W1589415602 @default.
• W2106867787 cites W1603128511 @default.
• W2106867787 cites W1970022901 @default.
• W2106867787 cites W1973792489 @default.
• W2106867787 cites W1975203613 @default.
• W2106867787 cites W1976692354 @default.
• W2106867787 cites W1977707442 @default.
• W2106867787 cites W1984696190 @default.
• W2106867787 cites W1991196959 @default.
• W2106867787 cites W1992060545 @default.
• W2106867787 cites W1999764514 @default.
• W2106867787 cites W2000593033 @default.
• W2106867787 cites W2002503549 @default.
• W2106867787 cites W2005189185 @default.
• W2106867787 cites W2015896553 @default.
• W2106867787 cites W2016136242 @default.
• W2106867787 cites W2020200222 @default.
• W2106867787 cites W2023380270 @default.
• W2106867787 cites W2028111124 @default.
• W2106867787 cites W2041466047 @default.
• W2106867787 cites W2054968862 @default.
• W2106867787 cites W2069321762 @default.
• W2106867787 cites W2070684476 @default.
• W2106867787 cites W2071621979 @default.
• W2106867787 cites W2075761806 @default.
• W2106867787 cites W2075809552 @default.
• W2106867787 cites W2089096618 @default.
• W2106867787 cites W2092378641 @default.
• W2106867787 cites W2099527168 @default.
• W2106867787 cites W2102612748 @default.
• W2106867787 cites W2112604847 @default.
• W2106867787 cites W2122458615 @default.
• W2106867787 cites W2134205510 @default.
• W2106867787 cites W2142563542 @default.
• W2106867787 cites W2142793471 @default.
• W2106867787 cites W2159550399 @default.
• W2106867787 cites W2170272735 @default.
• W2106867787 cites W2505644460 @default.
• W2106867787 cites W50394454 @default.
• W2106867787 doi "https://doi.org/10.1093/intimm/12.4.555" @default.
• W2106867787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10744657" @default.
• W2106867787 hasPublicationYear "2000" @default.
• W2106867787 type Work @default.
• W2106867787 sameAs 2106867787 @default.
• W2106867787 citedByCount "52" @default.
• W2106867787 countsByYear W21068677872015 @default.
• W2106867787 countsByYear W21068677872016 @default.
• W2106867787 countsByYear W21068677872018 @default.
• W2106867787 countsByYear W21068677872021 @default.
• W2106867787 countsByYear W21068677872022 @default.
• W2106867787 crossrefType "journal-article" @default.
• W2106867787 hasAuthorship W2106867787A5005814559 @default.
• W2106867787 hasAuthorship W2106867787A5009949893 @default.
• W2106867787 hasAuthorship W2106867787A5024900910 @default.
• W2106867787 hasAuthorship W2106867787A5028034613 @default.
• W2106867787 hasAuthorship W2106867787A5036360676 @default.
• W2106867787 hasAuthorship W2106867787A5045619704 @default.
• W2106867787 hasAuthorship W2106867787A5050918148 @default.
• W2106867787 hasAuthorship W2106867787A5063118578 @default.
• W2106867787 hasAuthorship W2106867787A5065959133 @default.
• W2106867787 hasAuthorship W2106867787A5069360454 @default.
• W2106867787 hasAuthorship W2106867787A5075593407 @default.
• W2106867787 hasAuthorship W2106867787A5090769439 @default.
• W2106867787 hasBestOaLocation W21068677871 @default.
• W2106867787 hasConcept C126322002 @default.
• W2106867787 hasConcept C159654299 @default.
• W2106867787 hasConcept C190283241 @default.
• W2106867787 hasConcept C203014093 @default.
• W2106867787 hasConcept C2522874641 @default.
• W2106867787 hasConcept C2776029263 @default.
• W2106867787 hasConcept C2776637226 @default.
• W2106867787 hasConcept C2777203481 @default.
• W2106867787 hasConcept C2779609443 @default.
• W2106867787 hasConcept C2780593183 @default.
• W2106867787 hasConcept C2911091166 @default.
• W2106867787 hasConcept C2911118192 @default.
• W2106867787 hasConcept C2994395758 @default.
• W2106867787 hasConcept C31573885 @default.
• W2106867787 hasConcept C502942594 @default.
• W2106867787 hasConcept C542903549 @default.
• W2106867787 hasConcept C55493867 @default.

• next